Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogenei...
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia
About this item
Full title
Author / Creator
Debureaux, Pierre-Edouard , Labopin, Myriam , Mamez, Anne-Claire , Lapusan, Simona , Isnard, Francoise , Adaeva, Rosa , Bonnin, Agnès , Hirsch, Pierre , Delhommeau, Francois , Battipaglia, Giorgia , Duléry, Remy , Malard, Florent , Vekhoff, Anne , Mohty, Mohamad , Legrand, Ollivier and Brissot, Eolia
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Optimization of the salvage regimen is required to improve prognosis in primary refractory or relapsed acute myeloid leukemia (AML). In fit patients, a bridge to allogeneic transplant is the primary purpose of salvage. We tested the combination of fractionated gemtuzumab ozogamicin with cytarabine and mitoxantrone (MYLODAM schema) with primary endp...
Alternative Titles
Full title
Fractionated gemtuzumab ozogamicin in association with high dose chemotherapy: a bridge to allogeneic stem cell transplantation in refractory and relapsed acute myeloid leukemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_02530730v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_02530730v1
Other Identifiers
ISSN
0268-3369
E-ISSN
1476-5365
DOI
10.1038/s41409-019-0690-2
